Brinzolamide

From Wikipedia, the free encyclopedia

Brinzolamide
Systematic (IUPAC) name
(5R)-5-ethylamino-3-(3-methoxypropyl)-
2,2-dioxo-2λ6,9-dithia-
3-azabicyclo[4.3.0]nona-7,10-diene-
8-sulfonamide
Identifiers
CAS number 138890-62-7
ATC code S01EC04
PubChem 68844
DrugBank APRD00475
Chemical data
Formula C12H21N3O5S3 
Mol. mass 383.51 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding ~60%
Metabolism  ?
Half life 111 days
Excretion  ?
Therapeutic considerations
Licence data

EUUS

Pregnancy cat.

C(US)

Legal status

-only(US)

Routes Ophthalmic

Brinzolamide is a carbonic anhydrase inhibitor.

[edit] References

  • Ermis S, Ozturk F, Inan U (2005). "Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.". Eye 19 (3): 303–7. doi:10.1038/sj.eye.6701470. PMID 15258611. 
  • Iester M, Altieri M, Michelson G, Vittone P, Traverso C, Calabria G. "Retinal peripapillary blood flow before and after topical brinzolamide.". Ophthalmologica 218 (6): 390–6. doi:10.1159/000080942. PMID 15564757. 
  • Kaup M, Plange N, Niegel M, Remky A, Arend O (2004). "Effects of brinzolamide on ocular haemodynamics in healthy volunteers.". Br J Ophthalmol 88 (2): 257–62. doi:10.1136/bjo.2003.021485. PMID 14736787. 
Languages